Metoclopramida Accord

Metoclopramide, the active ingredient in Metoclopramida Accord, is a dopamine D2 receptor antagonist presented as an oral tablet for oral use. It treats nausea and vomiting, gastroparesis, and gastro‑oesophageal reflux disease in adult patients. GNH USA supplies Metoclopramida Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramida Accord acts on dopamine pathways that influence nausea, gastric motility and reflux. - Nausea and vomiting: reduces the frequency and severity of episodes. - Gastroparesis: enhances gastric emptying and relieves associated symptoms. - Gastro‑oesophageal reflux disease: improves lower oesophageal sphincter tone and decreases reflux episodes.

Metoclopramida Accord may cause a range of adverse reactions.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Restlessness: inner sense of agitation or inability to stay still. - Diarrhoea: loose, frequent stools. - Dry mouth: reduced salivation. - Headache: mild to moderate head pain. - Fatigue: general lack of energy.

Serious or Rare Side Effects: - Extrapyramidal symptoms: involuntary muscle movements or tremors. - Tardive dyskinesia: persistent, potentially irreversible facial or tongue movements. - Neuroleptic malignant syndrome: rare, life‑threatening reaction with fever and rigidity. - Depression or suicidal thoughts: mood changes requiring immediate attention. - Seizures: convulsive episodes. - Hyperprolactinemia: elevated prolactin leading to hormonal disturbances.

Before prescribing Metoclopramida Accord, clinicians should consider several safety measures. - Assess renal function: dose adjustment may be needed in impaired kidneys. - Monitor for extrapyramidal symptoms: watch for muscle rigidity or tremor. - Use the lowest effective dose: limit exposure to reduce risk of tardive dyskinesia. - Avoid prolonged therapy: limit use to the shortest duration necessary. - Contraindicated in known hypersensitivity: discontinue if allergic reaction occurs. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Metoclopramida Accord can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Antipsychotics: increase risk of extrapyramidal reactions. - MAO inhibitors: may precipitate hypertensive crises. - CNS depressants: enhance sedation and respiratory depression. - CYP450 inhibitors: raise plasma concentrations of metoclopramide. - QT‑prolonging agents: elevate the chance of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Opioids: additive gastrointestinal effects and constipation. - Anticholinergics: may diminish metoclopramide’s pro‑kinetic action. - Alcohol: can intensify central nervous system depression. - Digoxin: possible alteration of serum levels. - SSRIs: potential for serotonin syndrome when combined.